Delivery Order SPE2DR25D1053-SPE2DR26FV795
Award Date 1/23/26
Potential Completion Date 1/26/26
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $47,526.27 to AmerisourceBergen Drug Corp for the supply of Deferasirox 360 mg tablets (30-count units). This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by September 5, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- This is a $55,877.06 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 360 mg Deferasirox tablets, a medication used to treat chronic iron overload. The award has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,882.12 to AmerisourceBergen Drug Corp for the supply of Deferasirox 360 mg tablets (30-count) on December 1, 2025, with completion scheduled for December 2, 2025. This firm fixed-price, non-set-aside contract was issued as a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling through December 2026....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Deferasirox 360 mg tablets (30-count) with a ceiling value of $48,938.95. This firm fixed-price delivery order, issued on December 2, 2025, with an ultimate completion date of December 3, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement...
- The Defense Logistics Agency awarded a $10,368 delivery order to AmerisourceBergen Drug Corp for Deferasirox 360 mg granule packets (30 count) on September 10, 2025, with a completion date of September 11, 2025. This firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 through December 2026. The award was competitively awarded without set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Deferasirox 360 mg tablets in a quantity of 30 units. This is a firm fixed price delivery order valued at $35,982.29, with a completion date of September 25, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a child contract under a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $2,415.26 contract is for the provision of the medication Deferasirox 500 mg tablets for suspension, with a completion date of February 15, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with a...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide the pharmaceutical product Deferasirox 500 mg tablets for suspension. The contract has a ceiling value of $2,455.30 and a period of performance through March 21, 2024. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the prime contractor on this delivery order, which is issued under a larger...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DEFERASIROX 360 MG TABLET 30S, a medical product, with a ceiling value of $54,663.84 and a performance period through May 20, 2025. The contract is a firm-fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the for-profit Amerisourcebergen Corporation. The contract is for the delivery of Deferasirox 500 mg tablets for suspension, with a completion date of February 1, 2024 and a potential value of $2,946.36. The contract is a firm fixed price delivery order and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and serves as a major...